Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age

American Journal of Medicine

Volumn 111, Issue 4, 2001, Pages 255-260

  Snyder, Peter J ^a,c   Peachey, Helen ^a   Berlin, Jesse A ^a   Rader, Daniel ^a   Usher, David ^b   Loh, Louise ^a   Hannoush, Peter ^a   Dlewati, Abdallah ^a   Holmes, John H ^a   Santanna, Jill ^a   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TESTOSTERONE; TRIACYLGLYCEROL;

AGED; ANDROGEN THERAPY; ARTERY EMBOLISM; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; HEART ARRHYTHMIA; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STROKE; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, CUTANEOUS; AGED; APOLIPOPROTEINS; BONE DENSITY; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPIDS; MALE; MUSCLES; STATISTICS, NONPARAMETRIC; TESTOSTERONE; TIME FACTORS;

EID: 0034833765     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00813-0     Document Type: Article

References (27)

1. Age differences in serum androgen levels in normal adult males
2. Leydig cell function in normal men: Effect of age, life-style, residence, diet, and activity
3. Longitudinal changes in testosterone, luteinizing hormone, and follicle stimulating hormone in healthy older men
4. Adult lean body mass declines with age: Some longitudinal observations
5. Strength of isometric and isokinetic contractions
6. Changes in bone mineral density of the proximal femur and spine with aging
7. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
8. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength, and adiposity
9. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men
10. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age
11. Endogenous sex hormones and cardiovascular disease in men
12. Effect of testosterone treatment on bone mineral density in men over 65 years of age
13. Transdermal delivery of testosterone
14. Enzymatic determination of total cholesterol in serum
15. Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment
16. Multilayer film elements for clinical analysis
17. A comparison of Lp(a) levels in fresh and frozen plasma using ELISAs with either anti-apo(a) or anti-apoB reporting antibodies
18. Effects of gonadotropin and testosterone treatments on lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism
19. Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men
20. Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol
21. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-1 containing lipoproteins
22. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men
23. Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels
24. Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-1 and lipoprotein(a)
25. Hormonal regulation of serum lipoprotein(a) levels: Effects of parenteral administration of estrogen or testosterone in males
26. Treatment of prostate cancer with gonadotropin-releasing hormone analogue: Effect on lipoprotein(a)